Search

everythinglearnresearchcommunity

for

Search:↓

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Immune cells are crucial for hair growth and preventing hair loss.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

A boy's growth and immune problems were caused by a new mutation in the STAT5B gene.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Transplanting melanocyte stem cells from hair follicles can effectively treat vitiligo.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Maintaining the right amount of retinoic acid is crucial for healthy hair and skin.

Pigs without the Hairless gene showed skin and thymus changes, useful for studying human hair disorders.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

Non-immune factors play a significant role in alopecia areata.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

The document concludes that while there are promising methods to control CRISPR/Cas9 gene editing, more research is needed to overcome challenges related to safety and effectiveness for clinical use.

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Various skin conditions can be treated effectively with different methods, such as discontinuing certain drugs, using specific vaccines, applying creams, and changing lifestyle habits like smoking and drinking.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Mogamulizumab can cause hair loss and skin rashes.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.